CleanSpace Holdings Limited (CSX.AX)
AUD 0.39
(-1.27%)
AUD 0.39
(-1.27%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 11.35 Million AUD | 141.57% |
| 2023 | 6.69 Million AUD | -73.08% |
| 2022 | 24.87 Million AUD | 2.13% |
| 2021 | 24.35 Million AUD | 300.18% |
| 2020 | 6.08 Million AUD | 16.58% |
| 2019 | 5.21 Million AUD | 17.18% |
| 2018 | 4.45 Million AUD | -4.09% |
| 2017 | 4.64 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 3.92 Million AUD | 0.0% |
| 2024 Q1 | 4.16 Million AUD | 35.17% |
| 2024 FY | 5.81 Million AUD | -13.19% |
| 2024 Q2 | 3.1 Million AUD | -25.46% |
| 2024 Q3 | 3.92 Million AUD | 26.52% |
| 2023 Q4 | 3.07 Million AUD | -32.8% |
| 2023 FY | 6.69 Million AUD | -73.08% |
| 2023 Q3 | 4.58 Million AUD | 27.56% |
| 2023 Q2 | 3.59 Million AUD | -35.06% |
| 2023 Q1 | 5.53 Million AUD | 30.9% |
| 2022 Q4 | 4.22 Million AUD | -30.78% |
| 2022 Q1 | 6.3 Million AUD | 35.22% |
| 2022 FY | 24.87 Million AUD | 2.13% |
| 2022 Q3 | 6.1 Million AUD | 7.95% |
| 2022 Q2 | 5.65 Million AUD | -10.34% |
| 2021 Q1 | 6.32 Million AUD | 122.21% |
| 2021 Q4 | 4.66 Million AUD | -3.88% |
| 2021 Q3 | 4.85 Million AUD | -21.34% |
| 2021 Q2 | 6.16 Million AUD | -2.48% |
| 2021 FY | 24.35 Million AUD | 300.18% |
| 2020 Q4 | 2.84 Million AUD | -24.63% |
| 2020 Q2 | 2.94 Million AUD | -4.27% |
| 2020 FY | 6.08 Million AUD | 16.58% |
| 2020 Q1 | 3.07 Million AUD | 0.0% |
| 2020 Q3 | 3.77 Million AUD | 28.16% |
| 2019 FY | 5.21 Million AUD | 17.18% |
| 2018 FY | 4.45 Million AUD | -4.09% |
| 2017 FY | 4.64 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| 4DMedical Limited | 31.48 Million AUD | 63.92% |
| Adherium Limited | 267.7 Thousand AUD | -4143.254% |
| Aroa Biosurgery Limited | 66.09 Million AUD | 82.815% |
| Atomo Diagnostics Limited | 1.6 Million AUD | -607.304% |
| Anteris Technologies Ltd | 69.14 Million AUD | 83.573% |
| Control Bionics Limited | 9.82 Million AUD | -15.606% |
| CardieX Limited | 16.64 Million AUD | 31.772% |
| Compumedics Limited | 26.88 Million AUD | 57.741% |
| Cochlear Limited | 1.17 Billion AUD | 99.033% |
| Cyclopharm Limited | 13.38 Million AUD | 15.108% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | 11.488% |
| Nova Eye Medical Limited | 23.99 Million AUD | 52.65% |
| HeraMED Limited | 6.78 Million AUD | -67.469% |
| Imricor Medical Systems, Inc. | -1.11 Million AUD | 1118.007% |
| ImpediMed Limited | 28.04 Million AUD | 59.49% |
| InhaleRx Limited | 2.59 Million AUD | -338.494% |
| LBT Innovations Limited | 1.1 Million AUD | -926.135% |
| Micro-X Limited | 18.76 Million AUD | 39.462% |
| Neurotech International Limited | 8.75 Million AUD | -29.757% |
| OncoSil Medical Limited | 12.03 Million AUD | 5.652% |
| PolyNovo Limited | 34.92 Million AUD | 67.472% |
| Respiri Limited | 8.03 Million AUD | -41.375% |
| SomnoMed Limited | 58.97 Million AUD | 80.738% |
| Universal Biosensors, Inc. | 20 Million AUD | 43.204% |
| Uscom Limited | 5.52 Million AUD | -105.783% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | -17.913% |